Abstract In gastrointestinal smooth muscle, agonists that bind to G i -coupled receptors activate preferentially PLC-b3 via Gbc to stimulate phosphoinositide (PI) hydrolysis and generate inositol 1,4,5-trisphosphate (IP 3 ) leading to IP 3 -dependent Ca 2? release and muscle contraction. In the present study, we identified the mechanism of inhibition of PLC-b3-dependent PI hydrolysis by cAMP-dependent protein kinase (PKA) and cGMP-dependent protein kinase (PKG). Cyclopentyl adenosine (CPA), an adenosine A 1 receptor agonist, caused an increase in PI hydrolysis in a concentration-dependent fashion; stimulation was blocked by expression of the carboxyl-terminal sequence of GRK2(495-689), a Gbc-scavenging peptide, or Ga i minigene but not Ga q minigene. Isoproterenol and S-nitrosoglutathione (GSNO) induced phosphorylation of PLC-b3 and inhibited CPA-induced PI hydrolysis, Ca 2? release, and muscle contraction. The effect of isoproterenol on all three responses was inhibited by PKA inhibitor, myristoylated PKI, or AKAP inhibitor, Ht-31, whereas the effect of GSNO was selectively inhibited by PKG inhibitor, Rp-cGMPS. GSNO, but not isoproterenol, also phosphorylated Ga i -GTPase-activating protein, RGS2, and enhanced association of Ga i3 -GTP and RGS2. The effect of GSNO on PI hydrolysis was partly reversed in cells (i) expressing constitutively active GTPase-resistant Ga i mutant (Q204L), (ii) phosphorylation-site-deficient RGS2 mutant (S46A/S64A), or (iii) siRNA for RGS2. We conclude that PKA and PKG inhibit Gbc i -dependent PLC-b3 activity by direct phosphorylation of PLC-b3. PKG, but not PKA, also inhibits PI hydrolysis indirectly by a mechanism involving phosphorylation of RGS2 and its association with Ga i -GTP. This allows RGS2 to accelerate Ga iGTPase activity, enhance Gabc i trimer formation, and inhibit Gbc i -dependent PLC-b3 activity.
Introduction
Contraction of smooth muscle is mediated by Ca 2? /calmodulin-dependent activation of myosin light chain (MLC) kinase and phosphorylation of MLC 20 , a prerequisite in acto-myosin interaction [1] [2] [3] [4] . Mobilization of intracellular Ca 2? by main contractile agonists such as acetylcholine, which activate G q -coupled m3 receptors, is mediated via Ga q -dependent activation of PLC-b1 isoform, whereas agonists such as adenosine, which activate G i -coupled A 1 receptors, is mediated via Gbc i -dependent activation of PLC-b3 isoform [5] [6] [7] [8] [9] .
The strength and duration of G protein signaling are regulated by 2 major mechanisms that accelerate intrinsic GTPase activity of Ga subunits: (i) through PLC-b1, which possesses GAP (GTPase-activating protein activity) in its C-terminal region and which stimulates Ga qGTPase activity and functions as both effector and terminator of Ga q signaling [10, 11] , and (ii) through family of GTPase-activating proteins (GAP) known as regulators of G protein signaling (RGS), which bind via their RGS domain to Ga subunits and, like PLC-b1, stimulate the intrinsic GTPase activity of Ga subunits [12, 13] . Accelerated hydrolysis of GTP to GDP by RGS proteins leads to re-association of Ga and Gbc and rapid cessation of Ga and Gbc signals. RGS proteins also bind to receptors via their N-terminal domain and thus, function as scaffolding proteins to modulate G protein signaling in a receptor-specific manner [13, 14] . In pancreatic acini, for example, RGS4 was found to be more effective in terminating G protein signals coupled to cholinergic receptors than G proteins coupled to bombesin and cholecystokinin [15] . The strength and duration of PLC-b activity are also regulated by a number of kinases, which function both in negative feedback regulation of PLC-b isoforms (e.g., protein kinase C-mediated regulation of PLC-b1) as well as in cross-regulation between signaling pathways (e.g., ERK1/ 2-mediated regulation of PLC-b1, and PKA-and PKGmediated regulation of PLC-b3) [16] [17] [18] [19] [20] [21] [22] [23] [24] . Regulation of PLC-b activity by protein kinases appears to be PLC-b isoform specific [21, 22] . The strength and duration of RGS activity are also regulated by intracellular mediators. RGS4 proteins bind Ca 2? /calmodulin complex and PIP3: the latter inhibits RGS GAP activity, and the Ca 2? / calmodulin complex antagonizes binding of PIP3 to RGS without affecting the GAP activity [25] . Regulation of RGS proteins by phosphorylation has also been reported in several studies. The results suggest that the effect of phosphorylation on RGS function is kinase-, site-, and cell-specific. For example: (i) phosphorylation of RGS4 increased GAP activity in cardiac myocytes and smooth muscle [26, 27] ; (ii) phosphorylation of RGS16 at S53 and S194 inhibited GAP activity, whereas phosphorylation at Y168 and Y177 by src kinase increased GAP activity [28] [29] [30] ; and (iii) phosphorylation of RGS2 at Ser46 and Ser64 by PKG increased GAP activity, whereas phosphorylation by PKC inhibited GAP activity [31] [32] [33] [34] . RGS2 is ubiquitously expressed, and a role for RGS2 in pathogenesis of hypertension has been implicated in humans. Studies using Rgs2 -/-mice and RGS2 knockdown in both human and mouse cells have suggested that it regulates GAP activity and increased vascular tone due to increased response to angiotensin II receptor [32] [33] [34] [35] [36] [37] .
We have reported that in smooth muscle, PLC-b1 activity was inhibited indirectly by both PKA and PKG via phosphorylation of RGS4 at Ser52 and acceleration of Ga q inactivation [27] . The regulation of Gbc i -mediated PLC-b3 activity is not clear. In the present study, we demonstrate that in gastric muscle cells, PLC-b3, unlike PLC-b1, is directly phosphorylated by both PKA and PKG. PLC-b3 is indirectly regulated via phosphorylation of RGS2 at Ser46/Ser64 by PKG only. Phosphorylation of PLC-b3 and RGS2 leads to inhibition of Gbc i -mediated PI hydrolysis, Ca 2? release, and initial muscle contraction. All animal procedures were conducted in accordance with the Institutional Animal Care and Use Committee of the Virginia Commonwealth University.
Materials and Methods

Materials
Preparation of Dispersed Gastric Smooth Muscle Cells
Smooth muscle cells from the circular muscle layer of the rabbit antrum were isolated by sequential collagenase digestion, filtration, and centrifugation as described previously [5] [6] [7] [8] [9] . The partly digested tissues were washed twice with 50 ml of collagenase-free smooth muscle buffer, and the muscle cells were allowed to disperse spontaneously for 30 min in collagenase-free medium. Cells were harvested by filtration through 500 lm Nitex and centrifuged twice at 3509g for 10 min to eliminate broken cells and organelles. Dispersed muscle cells were cultured in DMEM containing penicillin (200 U/ml), streptomycin (200 lg/ ml), gentamycin (100 lg/ml), amphotericin B (2.5 lg/ml), and 10 % fetal bovine serum (DMEM-10). All experiments were done on cells in the first passage.
Transfection of RGS Mutant, Minigene Constructs, and RGS2 siRNA into Cultured Smooth Muscle Cells Wild-type RGS2, phosphorylation-deficient RGS2(S46A/ S64A), and Ga-GTPase-resistant Ga i3 (Q204L) were subcloned into the multiple cloning site (EcoR1) of the eukaryotic expression vector pcDNA3. Recombinant plasmid DNAs were transiently transfected into the muscle cells in primary culture using Effectene Transfection Reagent (QIAGEN) for 48 h [27, 38] . Cells were co-transfected with 2 lg of pcDNA3 vector and 1 lg of pGreen Lantern-1 DNA. Transfection efficiency was monitored by the expression of the green fluorescent protein using FITC filters. Control cells were transfected with vector alone. Analysis by fluorescence microscopy showed that approximately 80 % of the cells were transfected.
The cDNA sequences encoding the last COOH-terminal 11 amino acids of Ga q and Ga i were amplified by PCR and verified by DNA sequencing as previously described [38] [39] [40] [41] . The oligonucleotide sequence corresponding to the COOH-terminal 11 amino acid residues of Ga i in random order was synthesized and ligated into pcDNA3.1(?) as a control minigene. All Ga minigene constructs used for transfection experiments were purified with an endotoxinfree maxiprep kit (Qiagen) following the manufacturer's protocol.
The RNAi-Ready pSIREN-DNR-DsRed-Express Vector (BD Biosciences, Clontech) encoding RGS2 smallinterfering RNA was inserted between BamH1 and EcoR1 restriction sites and transfected into cultured gastric smooth muscle cells with lipofectamine TM 2000 reagent (Invitrogen) according to the manufacturer's recommendation. To check the specificity of the siRNA, empty vector without the siRNA sequence was used as control. Successful knockdown of RGS2 protein was verified by western blot.
Assay for Phosphoinositide (PI) Hydrolysis (PLC-b Activity)
Total inositol phosphates were measured in rabbit gastric circular muscle cells by anion exchange chromatography using the method of Berridge et al. [42] as described previously [5] [6] [7] [8] [9] . Ten milliliter of cell suspension (2 9 10 6 -cells/ml) was labeled with myo-[ 3 H] inositol (15 lCi/ml) for 90 min at 31°C, and then, cells were centrifuged at 3509g for 10 min to remove excess [ 3 H]inositol and resuspended in 10 ml of fresh medium. CPA was added at different concentration to 0.5 ml of cell suspension for 1 min. Cultured smooth muscle cells were labeled with [ 3 H]myo-inositols (1.5 lCi/ml) for 24 h in inositol-free DMEM medium and then treated with CPA for 1 min. In some experiments, cells were preincubated with isoproterenol or GSNO for 10 min and then with CPA for 1 min. The reaction was terminated by the addition of chloroform:methanol:HCl (50:100:1 v/v/v). The upper aqueous phase was applied to a column containing 1 ml of 1:1 slurry of Dowex AG-1X8 resin (100-200 mesh in formate form) and distilled water. Total inositol phosphates were eluted with 6 ml of 0.8 M ammonium formate-0.1 M formic acid. The eluates were collected into scintillation vials and counted in gel phase after addition of 10 ml of scintillant. The results were expressed as counts per minute per mg protein.
Assay for Adenylyl Cyclase Activity Adenylyl cyclase activity was measured by the formation of cAMP in response to agonists by radioimmunoassay using [
125 I]cAMP as described previously [6] [7] [8] [9] . One milliliter (3 9 10 6 cells/ml) of cell suspension was treated with agonist in the presence of 100 lM isobutylmethylxanthine, either alone or in combination with CPA (1 lM). The reaction was terminated with 6 % cold trichloroacetic acid (v/v) and the supernatants were extracted three times with water-saturated diethyl ether to remove the tricholoroacetic acid and the samples were then lyophilized and frozen at -20°C. The samples were reconstituted for radioimmunoassay in 50 ll of 50 mM sodium acetate (pH 6.2) and acetylated with triethylamine/acetic anhydride (2:1 v/v) for 30 min. Cyclic AMP was measured in duplicates using 100-ll aliquots, and the results were computed from a standard curve using Prizm @ . The results are expressed as pmol of cAMP/mg protein.
Phosphorylation of PLC-b3 and RGS2
Protein phosphorylation was determined from the amount of 32 P incorporated into each protein after immunoprecipitation with specific antibody to PLC-b3 or RGS2 as previously described [27] . Freshly dispersed cells were incubated with [ 32 P]Pi for 4 h. One milliliter of samples was incubated with isoproterenol (10 lM) or GSNO (10 lM) for 10 min, and the reaction was terminated by rapid centrifugation. The pellet was homogenized in lysis buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1 % SDS, 0.5 % sodium deoxycholate, 1 % NP-40, 10 mM sodium pyrophosphate, and protease inhibitor cocktail (2 ll/ml). Cell lysates were separated by centrifugation at 13,0009g for 10 min at 4°C, precleared with 40 ll of protein A-Sepharose, and incubated with PLC-b3 or RGS2 antibody for 2 h at 4°C and with 40 ll of protein A-Sepharose for another 1 h. The immunoprecipitates were extracted with Laemmli sample buffer, boiled for 5 min, and separated by electrophoresis on SDS-PAGE. After transfer to nitrocellulose membranes, [ 32 P]PLC-b3 or RGS2 was visualized by autoradiography.
Ga i3 :RGS2 Association
Smooth muscle cells (3 9 10 6 cells/ml) treated with CPA in the presence or absence of GSNO (10 lM) or isoproterenol (10 lM) were lysed after an incubation for 30 min at 4°C in 10 mM Tris (pH 7.5), 50 mM NaCl, 1 % Triton X-100, and 60 mM octyl glucoside, and lysates were centrifuged at 15,0009g for 30 min. The supernatant was precleared by incubation with 40 ll of protein A-Sepharose for 4 h and then incubated overnight with the antibody to Ga i3 . Protein A-Sepharose was then added, and the mixture was incubated for 2 h and then centrifuged at 13,0009g for 5 min. Immunoprecipitates were washed four times in lysis buffer and boiled in Laemmli buffer. Samples were separated by SDS-PAGE, transferred to PVDF membranes, and probed with the antibody to RGS2. After incubation with secondary antibody, proteins were visualized by ECL, and the intensity of the protein band on ECL film was determined by densitometry [27] .
Release in Dispersed Muscle Cells Ca 2? release was measured in intact muscle cells by an adaptation of the method of Poggioli and Putney [43] as described previously [44] . The cells were incubated with 45 Ca 2? (10 lCi/ml), and Ca 2? uptake was measured at intervals for 90 min when a steady state was attained. After 90 min, CPA (1 lM) was added and the reaction was terminated after 30 s. Isoproterenol (10 lM) or GSNO (10 lM) was added 10 min before CPA. The decrease in 45 Ca 2? content, representing net Ca 2? efflux, was expressed as nanomoles per 10 6 cells.
Measurement of Contraction in Dispersed Smooth Muscle Cells
Contraction in freshly dispersed gastric circular smooth muscle cells was determined by scanning micrometry as previously described [5] [6] [7] [8] [9] . An aliquot (0.4 ml) of cells containing approximately 10 4 cells/ml was treated with 100 ll of medium containing various concentrations of CPA for 30 s, and the reaction was terminated with 1 % acrolein at a final concentration of 0.1 %. In some experiments, cells were incubated with isoproterenol (10 lM) or GSNO (10 lM) for 10 min and then treated with CPA for 30 s. The mean lengths of 50 muscle cells treated with agonists were measured by scanning micrometry and compared with the mean lengths of untreated cells. The contractile response was expressed as the percent decrease in mean cell length from control cell length.
Statistical Analysis
The results were expressed as means ± SE of n experiments and analyzed for statistical significance using Student's t test for paired and unpaired values. Each experiment was done on cells obtained from different animals. A probability of p \ 0.05 was considered significant.
Results
Stimulation of PI hydrolysis by Cyclopentyl Adenosine (CPA) Via Gbc i
Treatment of dispersed gastric muscle cells with adenosine A 1 selective receptor agonist CPA caused an increase in PI hydrolysis in a concentration-dependent manner (EC 50 3 ± 1 nM) (Fig. 1a) . A maximal stimulation of 3956 ± 654 above basal levels of 623 ± 84 cpm/mg protein was obtained at 1 lM CPA. Previous studies have shown that A 1 receptors are coupled to pertussis toxin-sensitive G i3 and muscarinic m3 receptors are coupled to G q in gastrointestinal smooth muscle [7] . Activation of m3 receptors stimulates PLC-b1 via Ga q , whereas activation of A 1 receptors stimulates PLC-b3 isoform via Gbc [4, 5, 7] . The involvement of Gbc derived from G i3 in the activation of PI hydrolysis by A 1 receptor agonist CPA was examined in cultured muscle cells expressing G i minigene or carboxyl-terminal sequence of GRK2(495-689), a Gbc-scavenging peptide. CPA (1 lM) caused stimulation of PI hydrolysis in cultured muscle cells which was similar to that in dispersed muscle cells. CPAinduced stimulation of PI hydrolysis was significantly inhibited in cells expressing Ga i minigene (76 ± 5 % inhibition, p \ 0.01) or Gbc peptide (81 ± 6 % inhibition, p \ 0.01), but not in cells expressing Ga q minigene (3 ± 5 % inhibition, NS) (Fig. 1b) . Control studies showed that stimulation of PI hydrolysis in response to Ga q -coupled m3 receptor activation by acetylcholine was significantly inhibited (78 ± 7 %, p \ 0.01) in cells expressing Ga q minigene (485 ± 32 % increase in PI hydrolysis in control cells and 75 ± 6 % increase in cells expressing Ga q minigene). Previous studies have shown that adenosine-stimulated PI hydrolysis in muscle membranes was selectively blocked by Ga i3 -and Gbc-specific antibodies, as well as by a PLC-b3-specific antibody, but not by antibodies to other PLC-b isoforms or G protein subunits, suggesting activation of PLC-b3 via Gbc i [7] .
Inhibition of CPA-stimulated PI Hydrolysis by PKA and PKG Selective activators of cAMP/PKA (isoproterenol) or cGMP/PKG (GSNO) pathway were used to examine the effect of PKA and PKG on CPA-stimulated PI hydrolysis [27, 45] . Pretreatment of cells with isoproterenol or GSNO for 10 min inhibited CPA (1 lM)-induced PI hydrolysis in a concentration-dependent manner (Fig. 2a) . Maximal inhibition induced by GSNO (87 ± 6 % inhibition) was significantly higher than isoproterenol (53 ± 5 % inhibition), suggesting that PKG is more effective in the inhibition of CPA-induced PI hydrolysis. An alternative explanation is that the effect of isoproterenol via Gs/ cAMP/PKA pathway was attenuated by simultaneous activation of Ga i3 by CPA and inhibition of cAMP formation [7] .
To further examine if PKG is more effective than PKA to mediate inhibition of PI hydrolysis in response to CPA, cell permeable analogs of cAMP and cGMP that selectively activate PKA (cBIMPS) or PKG (8-pCPT-cGMP) were used. Both cBIMPS and 8-pCPT-cGMP caused inhibition of CPA (1 lM)-induced PI hydrolysis in a concentration-dependent manner (Fig. 2b) . Maximal inhibition induced by 8-pCPT-cGMP (80 ± 4 % inhibition) was significantly higher than cBIMPS (56 ± 5 % inhibition) confirming the results with isoproterenol and GSNO.
GSNO (10 lM)-induced inhibition of PI hydrolysis was blocked by a selective inhibitor of PKG, Rp-cGMPS (1 lM), but was not affected by the PKA inhibitor, myristoylated PKI 14-22 amide (1 lM) (Fig. 3a) . In contrast, isoproterenol (10 lM)-induced inhibition of PI hydrolysis was blocked by myristoylated PKI, but was not affected by Rp-cGMPS (Fig. 3b) , suggesting selective activation of PKG by GSNO and PKA by isoproterenol. Previous studies showed that A-kinase-anchoring protein (AKAP) plays an important role in targeting PKA to different subcellular compartments and mediating the PKA effects on target proteins [46, 47] . A short peptide (Ht-31) derived from PKA-binding amphipathic helix of AKAP was used to disrupt PKA docking to AKAP to examine the involvement of AKAP in PKA-induced inhibition of PI hydrolysis [46, 47] . Pretreatment of cell with Ht-31 reversed the effect of isoproterenol, but not GSNO, on CPA-induced PI hydrolysis, suggesting the involvement of AKAP in PKA-mediated inhibitory effect (Fig. 3b) . Treatment of cells with Rp-cGMPS (1 lM), myristoylated PKI (1 lM), or Ht-31 (10 lM) in the absence of isoproterenol or GSNO had no effect on either basal (456 ± 58-612 ± 89 cpm/mg protein) or CPA-stimulated (3325 ± 425-3502 ± 564 cpm/mg protein) PI hydrolysis.
Phosphorylation of PLC-b3 and RGS2 by PKA and PKG Both GSNO (10 lM) and isoproterenol (10 lM) phosphorylated PLC-b3 in dispersed muscle cells (Fig. 4) .
Phosphorylation of PLC-b3 by GSNO was blocked by RpcGMPS but was not affected by myristoylated PKI or Ht-31 (Fig. 4a) . In contrast, phosphorylation of PLC-b3 by isoproterenol was blocked by myristoylated PKI and Ht-31, but was not affected by Rp-cGMPS (Fig. 4b) . This pattern of inhibition is consistent with reversal of isoproterenolinduced inhibition of PI hydrolysis by myristoylated PKI or GSNO, but not isoproterenol, also phosphorylated RGS2, an activator of Ga-GTPase (Fig. 5) . Phosphorylation of RGS2 by GSNO was blocked by Rp-cGMPS, but was not affected by myristoylated PKI (Fig. 5) .
Inhibition of CPA-Induced PI Hydrolysis by PKG is Mediated Via RGS2 Phosphorylation at Ser46/Ser64
We examined the hypothesis that phosphorylation of RGS2 increased its association with Ga i3 .GTP leading to rapid hydrolysis and inactivation of Ga i3 using several approaches. In the first approach, cells were transfected with RGS2 siRNA to suppress the endogenous RGS2 levels. Expression of RGS2 siRNA significantly augmented (1211 ± 45 % increase) the PI hydrolysis in response to CPA compared to cells expressing control vector (728 ± 15 % increase), suggesting that RGS2 is involved in the augmentation of Ga i3 -GTPase activity and that suppression of Ga i .GTPase activity by RGS2 siRNA augments Gbc-mediated PI hydrolysis (Fig. 6a) . GSNOinduced inhibition of PI hydrolysis was significantly attenuated by RGS2 siRNA (48 ± 3 % inhibition vs. 85 ± 6 % inhibition in control cells), suggesting that inhibition of PI hydrolysis by PKG was partly mediated via activation of RGS2. Isoproterenol-induced inhibition of PI hydrolysis was also attenuated by RGS2 siRNA (26 ± 3 % inhibition vs. 56 ± 4 % inhibition in control cells) (Fig. 6a) .
In the second approach, cells were transfected with phosphorylation-deficient RGS2(S46A/S64A) to preclude the effect of PKG. Expression of RGS2(S46A/S64A) had no effect on CPA-induced increase in PI hydrolysis (811 ± 58 % increase vs. 853 ± 38 % increase in control cells) (Fig. 6b) . These results suggest that stimulation of Gai-GTPase activity was not affected by RGS2(S46A/ S64A). GSNO-induced inhibition of PI hydrolysis, however, was significantly attenuated in cells expressing RGS2(S46A/S64A) (46 ± 5 % inhibition) compared to control cells (84 ± 8 % inhibition), suggesting that phosphorylation increased the function of RGS2 and that inhibition of PI hydrolysis by GSNO was partly mediated via phosphorylation of RGS2 at Ser46/Ser64 (Fig. 6b) . Isoproterenol-induced inhibition of PI hydrolysis was not affected by RGS2 (S46A/S64A) (51 ± 3 % inhibition vs. 53 ± 6 % inhibition in control cells) (Fig. 6b) .
In the third approach, constitutively active Ga i3 mutant (Q204L) that is resistant to GTPase activity was used [48] . Expression of constitutively active Ga i mutant (Q204L) significantly augmented (1,016 ± 24 % increase) the PI hydrolysis in response to CPA compared to cells expressing control vector (634 ± 28 % increase) (Fig. 6c) . The increase reflects augmentation of Gbcdependent PI hydrolysis due to inhibition of GTP hydrolysis and resultant Gabc trimer formation. Inhibition of PI hydrolysis by GSNO was significantly attenuated in cells expressing Ga i3 (Q204L) (50 ± 4 % inhibition) compared to control cells (75 ± 5 % inhibition), suggesting that inhibition of PI hydrolysis by GSNO was partly mediated via activation of Ga i .GTPase activity, possibly via RGS2 phosphorylation. Isoproterenol-induced inhibition of PI hydrolysis was also attenuated by Ga i3 (-Q204L) (26 ± 3 % inhibition) compared to control cells (53 ± 5 % inhibition).
Although there was no effect of isoproterenol on RGS2 phosphorylation, its inhibitory effect on CPA-induced PI hydrolysis was attenuated in cells expressing RGS2 siRNA or Ga i mutant (Q204L). This could be due to augmentation of Ga i function by suppression of RGS2 or expression of Ga i -GTPase-resistant Ga i3 (Q204L) leading to greater inhibition of cAMP. This notion was confirmed by measurements of Ga i3 function in control cells and cells expressing Ga i3 (Q204L) or RGS2 siRNA. The function of Ga i3 was measured as inhibition of isoproterenol-stimulated cAMP formation by CPA.
In control cells, isoproterenol-stimulated cAMP formation (795 ± 35 % increase above basal levels of 2.62 ± .031 pmol/mg protein) was significantly inhibited (43 ± 3 %) in the presence of CPA (452 ± 21 % increase) (Fig. 7) . Expression of Ga i (Q204L) had no effect on isoproterenol-stimulated cAMP formation (824 ± 28 % increase), but the inhibition by CPA was augmented (74 ± 5 % inhibition) resulting in less cAMP than the control cells (Fig. 7) . Similarly, expression of RGS2 siRNA had no effect on isoproterenol-stimulated cAMP formation (978 ± 42 % increase), but the inhibition by CPA was augmented (78 ± 7 % inhibition) resulting in less cAMP than the control cells (Fig. 7) . This attenuation of isoproterenol-stimulated cAMP levels and resultant decrease in PKA activity could explain the reduction in the inhibition of PI hydrolysis by isoproterenol in cells expressing Ga i3 (Q204L) or RGS2 siRNA compared to control cells. In contrast, expression of RGS2(S46A/S64A) had no effect on either isoproterenol-stimulated cAMP levels (851 ± 42 % increase) or inhibition (45 ± 6 %) of isoproterenol-induced cAMP formation by CPA compared to control cells (Fig. 7) . This is consistent with the lack of effect of RGS2(S46A/S64A) expression on inhibition of PI hydrolysis by isoproterenol.
Augmentation of CPA-Induced Ga i3 -RGS2 Association by PKG Activation of A 1 receptors with CPA increased Ga i3 -RGS2 association. In the presence of GSNO, CPA-induced association of Ga i3 -RGS2 was augmented (Fig. 8) . Expression of RGS2(S46A/S64A) did not affect the increase in the association of RGS2 with Ga i3 in response to CPA, but blocked the stimulatory effect of GSNO on RGS2:Ga i3 association (Fig. 8) . The pattern reflected that PKG-mediated phosphorylation of RGS2 caused greater association with activated Ga i3 -GTP and suggested that inhibition of PI hydrolysis by PKG was partly due to increased hydrolysis of Ga i3 -GTP by RGS2. Isoproterenol had no effect on CPAinduced increase in the association of Ga i3 -GTP consistent with the lack of effect of isoproterenol on phosphorylation of RGS2. release (36 ± 3 % release) from the resting steady-state Ca 2? levels (2.23 ± 0.31 nmoles/10 6 cells). CPA-induced Ca 2? release was significantly inhibited by pretreatment of cells with GSNO (78 ± 4 % inhibition) and isoproterenol (53 ± 4 % inhibition) (Fig. 9) . Inhibition of CPA-induced Ca 2? release by GSNO and isoproterenol could reflect inhibition of PLC-b3 activity and/or inhibition of IP 3 -induced Ca 2? release. Inhibition of Ca 2? in response to GSNO was significantly higher than the inhibition in response to isoproterenol. The results are consistent with the greater inhibition of CPA-induced PI hydrolysis by GSNO and preferential phosphorylation of IP 3 receptor I (IP 3 RI) by PKG leading to inhibition of IP 3 -mediated Ca 2? release [49, 50] . Isoproterenol-induced inhibition of Ca 2? release was blocked by myristoylated PKI (11 ± 4 % inhibition) or Ht-31 (14 ± 2 % inhibition), but was not affected by Rp-cGMPS (48 ± 2 % inhibition) (Fig. 9) . In contrast, GSNO-induced inhibition of Ca 2? release was blocked by Rp-cGMPS (7 ± 4 % inhibition), but was not affected by myristoylated PKI (74 ± 3 % inhibition) or Ht-31 (71 ± 6 % inhibition) (Fig. 9) .
Increase in cytosolic Ca 2? in smooth muscle causes stimulation of Ca 2? /calmodulin-dependent MLC kinase activity and increases MLC 20 phosphorylation and muscle contraction. Treatment of cells with CPA caused a 33 ± 4-lm decrease in muscle cell from the control cell length of 105 ± 6 lM. CPA-induced muscle contraction was inhibited (i.e., relaxation) by isoproterenol and GSNO in a concentration-dependent manner (Fig. 10a) . Maximal inhibition of contraction was similar with isoproterenol (72 ± 6 % relaxation) and GSNO (83 ± 5 % relaxation). This is in contrast to the greater inhibition of PI hydrolysis by GSNO compared to isoproterenol, and this could be due to the fact that PKA could act on more than one locus downstream of PLC-b3 activation to mediate relaxation. Isoproterenol-induced inhibition of contraction was blocked by myristoylated PKI (16 ± 4 % inhibition) or Ht-31(9 ± 5 % inhibition), but was not affected by Rp-cGMPS (71 ± 6 % inhibition) (Fig. 10b) . In contrast, GSNO-induced inhibition of contraction was blocked by Rp-cGMPS (7 ± 2 % Fig. 8 Phosphorylation of RGS2 by PKG increases its association with Ga i3 -GTP. Smooth muscle cells expressing wild-type RGS2 or phosphorylation-deficient RGS2(S46A/S64A) were treated with CPA (1 lM) in the presence or absence of GSNO (10 lM). Immunoprecipitates derived from 500 lg of proteins using Ga i3 antibody were separated by SDS-PAGE and immunoblotted using RGS2 antibody. Values are mean ± SE of 4 experiments. *p \ 0.05 significant increase of CPA-induced association of RGS2-Ga i3 by GSNO inhibition), but was not affected by myristoylated PKI 14-22 amide (77 ± 4 % inhibition) or Ht-31 (80 ± 3 % inhibition) (Fig. 10b) . 20 , an essential step in smooth muscle contraction [1] [2] [3] [4] . Activation of cAMP-dependent protein kinase (PKA) or cGMP-dependent protein kinase (PKG) in response to relaxant agonists results in the inhibition of Ca 2? mobilization leading to inhibition of MLC kinase activity and MLC 20 dephosphorylation, an essential step in smooth muscle relaxation [4, 45] . Inhibition by PKG and/or PKA reflects their action on various targets in the signaling pathways that increase cytosolic Ca 2? . We have identified 3 such targets in the Ca 2? -dependent contraction: (i) RGS4, which accelerates inactivation of Ga q -GTP and termination of Ga q signaling [27] ; (ii) IP 3 receptor 1 (IP 3 R-I), which regulates Ca 2? release from sarcoplasmic stores in response to IP 3 generation [49, 50] ; and (iii) phospholamban, which regulates sarco-endoplasmic reticulum Ca 2? pump (SERCA) activity [51] . Neither Ga q nor PLC-b1 is phosphorylated by PKA or PKG [27, 52, 53] . Phosphorylation of RGS4 by both PKA and PKG leads to increase in Ga q -GTPase activity and decrease in PLC-b1 activity and IP 3 generation. Phosphorylation of IP 3 RI by PKG, but not PKA, leads to decrease in the IP 3 -mediated Ca 2? release, whereas phosphorylation of phospholamban by PKG leads to increase in SERCA activity and Ca 2? sequestration. PKA and PKG are also shown to regulate plasmalemmal Ca 2? and K ? channels [54, 55] . Phosphorylation of one or more of these targets should lead to a decrease in cytosolic Ca 2? and Ca 2? -dependent muscle contraction (Fig. 11) .
Muscle contraction in the gastrointestinal tract can be modulated by various endogenous agonists, such as release, and muscle contraction. In addition, PKG, but not PKA, phosphorylated RGS2 leading to stimulation of intrinsic Ga i -GTPase activity and termination of a-mediated inhibition of adenylyl cyclase (AC) activity and bc-mediated stimulation of PI hydrolysis adenosine, opioid peptides, and somatostatin. These agonists activate specific receptors (adenosine A 1 , opioid l, d, j, and somatostatin sst 3 ) coupled to G i and mobilize Ca 2? via activation of PLC-b3 by Gbc i [6] [7] [8] [9] . In the present study, we have shown that, unlike PLC-b1, PLC-b3 is phosphorylated by PKA and PKG and the phosphorylation leads to inhibition of PLC-b3 activity. PLC-b3 activity is also regulated via phosphorylation of RGS2 at Ser 46/64 by PKG only. Phosphorylation of RGS2 increases its association with Ga i3 -GTP, accelerates inactivation of Ga i3 , and trimer formation and thus, terminates both Ga i -dependent inhibition of adenylyl cyclase activity and Gbc i -dependent PLC-b3 activity. The evidence can be summarized as follows: (i) activators of PKA and PKG induced phosphorylation of PLC-b3 and inhibited PI hydrolysis; (ii) the effect of PKA activators was selectively blocked by the PKA inhibitor, myristoylated PKI, whereas the effect of PKG activators was selectively blocked by PKG inhibitor, RpcGMPS; and (iii) PKG, but not PKA, also phosphorylated Ga i -GTPase-activating protein RGS2 and enhanced its association with Ga i3 -GTP leading to inactivation of Gbc idependent PI hydrolysis. The notion that PKG-induced phosphorylation of RGS2 results in the inhibition of Gbc idependent PI hydrolysis was corroborated using 3 different complimentary approaches. In the first approach, we used GTPase-resistant Ga i mutant Ga i3 (Q240L) to block Ga i -GTP hydrolysis by RGS2, in the second approach, phosphorylation-deficient RGS2(S46A/S64A) was used to block PKG-mediated phosphorylation and augmentation of Ga i -GTP association, and in the third approach, RGS2 expression was suppressed to inhibit Ga i -GTP hydrolysis. Inhibition of CPA-induced PI hydrolysis by GSNO was partly reversed in cells expressing Ga i3 (Q204L), RGS2 (S46A/S64A), or RGS2 siRNA providing evidence that PKG-mediated phosphorylation of RGS2 accelerates Ga iGTPase activity and inhibits Gbc i -dependent PLC-b3 activity. Increase in Ga i -GTP hydrolysis causes termination of Gbc signaling, because the regions of Gbc that interact with effectors such as PLC-b3 and Ga overlap and Gbc interacts with either Ga or PLC-b3, but not with both simultaneously [18] .
The ability of PKA to phosphorylate PLC-b3 and inhibit its activity was reported in previous studies [20] [21] [22] . Phosphorylation of PLC-b3 at Ser1105 was shown to inhibit PLC-b3 activation by Ga q without affecting activation by Gbc i suggesting that PKA inhibits Gbc i -dependent activity via a distinct mechanism that does not involve phosphorylation at Ser1105. Gbc interacts with more than one region of PLC-b3 and differs from the Ga q , which interacts with C-terminus of PLC-b3 [18] . Possible involvement of phosphorylation sites in the N-terminal region of PLC-b3 was also examined and found to be that one of the potential sites Ser26 was without any effect on stimulation of PLC-b3 activity by Gbc [21, 22] . Thus, the identification of sites of phosphorylation and mechanism of inhibition of Gbc-stimulated PLC-b3 activity awaits further work. A-kinase-anchoring proteins (AKAP) are signaling scaffolds that regulate cAMP signaling by targeting PKA to specific cellular substrates [46, 47] . Blockade of PKA-, but not PKG-,induced PLC-b3 phosphorylation and inhibition of its activity by Ht-31 suggest that PKAinduced phosphorylation of PLC-b3 and inhibition of CPAinduced PLC-b3 activity require the association of PLC-b3 with AKAP [56] .
Both Ga q -and Gbc-stimulated PLC-b activity is terminated by intrinsic GTPase activity of Ga subunits, and the rate of inactivation is significantly augmented by the GTPase-activating property of PLC-b isoforms as well as by RGS proteins [10] [11] [12] [13] [14] . RGS proteins bind to switch regions in the activated Ga subunits via their conserved RGS domain and accelerate the intrinsic GTPase activity [12, 13] . Our studies show that phosphorylation of RGS2 by PKG augments the association of Ga i3 .RGS2 leading to acceleration of GTP hydrolysis to GDP and termination of both Ga i -and Gbc-dependent effector activity.
Accumulating evidence shows that termination of G protein signaling by RGS2 plays an important role in the regulation of vascular smooth muscle tone [32] [33] [34] [35] [36] [37] . An inverse correlation between RGS2 expression and blood pressure has been suggested: RGS2 knockout mice exhibit hypertension phenotype, and the effect of PKG to inhibit Ca 2? release and muscle contraction was greatly suppressed in these mice [35] [36] [37] . Our studies show that, unlike PKA, PKG-mediated inhibition of PI hydrolysis was also mediated by phosphorylation of RGS2. Suppression of RGS2 expression and expression of phosphorylation-deficient RGS2 (S46A/S64A) shed further light on the role of PKGmediated phosphorylation of RGS2 in the inhibition of PI hydrolysis by GSNO, but not isoproterenol. The N-terminal domain of RGS2 binds directly to the N-terminal leucinezipper domain of PKG-Ia, the predominant PKG isoform in smooth muscle [32] . RGS2 possesses poor GAP activity for Ga i in vitro, and this is attributed to the structural hindrance of RGS to bind to switch regions of Ga i [57, 58] . The N-terminus 78 amino acid of RGS2 is important for membrane targeting and function. Phosphorylation of RGS2 at the N-terminus by PKG may increase its membrane targeting, facilitate binding of RGS2, and/or increase its GTPaseactivating potency for Ga i [57] . RGS2-mediated suppression of Ga i/o was also reported in previous studies: it regulates presynaptic Ca 2? channels via Gbc subunits derived from Ga i/o in hippocampal neurons [59] , carbachol-stimulated ERK and Akt activity via Ga i/o in COS cells [60] , and parathyroid hormone-stimulated cAMP function by RGS2 via Ga s in osteoblasts [61] . RGS2 protein, in addition, can bind effector enzymes such as adenylyl cyclase to regulate Cell Biochem Biophys (2014) 70:867-880 877 their activity despite lacking GAP activity toward Ga s [57] . Recent studies, using endothelium-specific RGS2 knockout mice, have shown that RGS2 deficiency impairs vascular relaxation by augmentation of Ga i signaling in endothelium [31] . In summary, we have identified a mechanism by which PKA and PKG inhibit Gbc-dependent PI hydrolysis to mediate muscle relaxation. Both PKA and PKG phosphorylate PLC-b3. PKG, but not PKA, also phosphorylates RGS2, stimulating its binding to Ga i -GTP to enhance intrinsic GTPase activity of Ga i3 , and thus promoting reconstitution of heterotrimer Gabc. Both PKA and PKG also inhibited CPA-induced Ca 2? release and muscle contraction in freshly dispersed gastric muscle cells. Our previous studies have shown that in vivo PKG, but not PKA, phosphorylates IP 3 R-I and inhibits Ca 2? release [50] . Although phosphorylation of IP 3 R-I results in the decrease in Ca 2? and contraction, and RGS2 is one of the several molecules that mediate the actions of PKG, the importance of PLC-b3 inhibition by direct phosphorylation and indirect regulation via RGS2 resides in their location at the start of the signaling cascade leading to suppression of multiple distal signaling molecules concomitantly. The convergence of PLC-b3 phosphorylation and RGS2 phosphorylation to inhibit IP 3 formation underscores this proximal step in mediating relaxation.
